Belimumab 200mg pfs
| Product Overview | |
| Generic Name | Belimumab 200mg pfs |
| Brand Name(s) | BENLYST SC |
| Product Type | Originator Brand |
| Form | 4 pfs/box, solution for subcutaneous injection, single-dose prefilled syringe |
| Strength | 200 mg / 1 mL |
| Therapeutic Class | B-lymphocyte stimulator / BLyS / BAFF-specific inhibitor |
| ATC Code | L04AG04 |
| Manufacturing & Regulatory | |
| Manufacturer | GSK |
| Country | UK |
| GMP Compliance | WHO-GMP |
| COFEPRIS | 010.000.7064.00 |
| Logistics & Export | |
| MOQ | 5 units |
| Shelf Life | 36 months |
| Storage | 2°C to 8°C refrigerated; do not freeze; protect from light |
| Incoterms | EXW/FOB/CIF negotiable |
| Lead Time | 7 - 10 Business Days |
| Documentation | |
| Certificate of Analysis (COA) | available from manufacturer/authorised distributor for commercial procurement |
| SDS | SDS for finished pharmaceutical biological product |
Description
This is Originator brand "BENLYSTA SC" (belimumab) 200mg x 4/pfs
